News and insights
Never miss a breakthrough by signing up to our newsletter
Hocoma Introduces Brand New Andago® Mobile Robot for Body-weight Supported Gait Training in the US at AAPM&R Conference
The global world leader in functional movement therapy will open up new perspectives in functional gait therapy with dynamic body weight support.
Hocoma Launches the World’s First Robotic Exoskeleton for Integrated Arm and Hand Rehabilitation
Uplifting Ad for a Serious Cause – Creative Promotion Attracts Attention for Rehabilitation Centre
Hocoma Launches Erigo®Pro With Integrated Functional Electrical Stimulation (FES) for U.S. Market
Advantages of Armeo®power Therapy After Stroke
Volketswil, Switzerland, February 18, 2014 – Robotic training with the ArmeoPower, an arm exoskeleton by the Swiss medical device company Hocoma, reduces motor impairment faster and more effectively than conventional therapy after stroke. This is the result of a multicenter study1 by Verena Klamroth-Marganska, Robert Riener and other scientists of the ETH Zurich, that was recently published in "The Lancet Neurology".
Hocoma Offers the World’s Only Upper Extremity Therapy Concept That Covers All Stages of Recovery
Launch of the World’s First Commercially Available Robotic Arm Exoskeleton
After being the first to release a robotic gait orthosis in 2001, the Swiss medical technology company Hocoma now presents the world’s first commercially available robotic arm exoskeleton. As a part of the established Armeo® Therapy Concept, the ArmeoPower was designed for severely affected individuals who have suffered neurological disorders resulting in hand and arm impairment. The ArmeoPower provides an assist-as-needed support in an extensive 3D workspace and a virtual reality exercise environment for a higher patient motivation. The ArmeoPower will further expand Hocoma’s market leadership in robotic rehabilitation therapy.